Abstract
Dilated cardiomyopathy (DCM) is a myocardial disease characterized by bilateral or left ventricular cardiac dilation and systolic dysfunction that can lead to heart failure and sudden cardiac death in children. Many studies have focused on genetic variation in DCM-related genes in adult populations; however, the mutational landscape in pediatric DCM patients remains undetermined, especially in the Chinese population. We applied next-generation sequencing (NGS) technology to genetically analyze 46 pediatric DCM patients to reveal genotype–phenotype correlations. Our results indicated DCM-associated pathogenic mutations in 10 genes related to the structure or function of the sarcomere, desmosome, and cytoskeleton. We also identified 6 pathogenic mutations (5 novel) in the Titin (TTN) gene that resulted in truncated TTN variants in 6 (13%) out of 46 patients. Correlations between TTN mutations and clinical outcomes were assessed. Our data indicate that one-third of pediatric DCM cases are caused by genetic mutations. The role of TTN variants should not be underestimated in pediatric DCM and age-dependent pathogenic penetrance of these mutations should be considered for familial DCM cases. We argue that genetic testing of DCM cases is valuable for predicting disease severity, prognosis, and recurrence risk, and for screening first-degree relatives.
Similar content being viewed by others
Data Availability
The data and materials are available upon request.
Code Availability
N/A.
Abbreviations
- ACMG:
-
American College of Medical Genetics and Genomics
- ALT:
-
Alanine transaminase
- AST:
-
Aspartate transaminase
- CT:
-
Computed tomography
- DCM:
-
Dilated cardiomyopathy
- FLNC :
-
Filamin C
- HGMD:
-
Human Gene Mutation Database
- LVEDD:
-
Left ventricular end-diastolic diameter
- LVEF:
-
Left ventricular ejection fraction
- LVNC:
-
Left ventricular noncompaction
- MYH7 :
-
β-Myosin heavy chain
- NEXN :
-
Nexilin F-actin binding protein
- NKX2-5 :
-
NK2 homeobox 5
- NGS:
-
Next generation sequencing
- NT-proBNP:
-
N-terminal pro-brain-natriuretic peptide
- PRDM16 :
-
Positive regulatory domain16
- RBM20 :
-
RNA-binding protein20
- TNNI3 :
-
Troponin I3
- TNNT2 :
-
Troponin T2
- TTN :
-
Titin
- VCL :
-
Vinculin
- WES:
-
Whole-exome sequencing
References
Taylor MR, Carniel E, Mestroni L (2006) Cardiomyopathy, familial dilated. Orphanet J Rare Dis 1:27. https://doi.org/10.1186/1750-1172-1-27
Puggia I, Merlo M, Barbati G, Rowland TJ, Stolfo D, Gigli M, Ramani F, Di Lenarda A, Mestroni L, Sinagra G (2016) Natural history of dilated cardiomyopathy in children. J Am Heart Assoc 5(7):12. https://doi.org/10.1161/jaha.116.003450
Nugent AW, Daubeney PE, Chondros P, Carlin JB, Cheung M, Wilkinson LC, Davis AM, Kahler SG, Chow CW, Wilkinson JL, Weintraub RG (2003) The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med 348(17):1639–1646. https://doi.org/10.1056/NEJMoa021737
Wilkinson JD, Sleeper LA, Alvarez JA, Bublik N, Lipshultz SE (2008) The pediatric cardiomyopathy registry: 1995–2007. Prog Pediatr Cardiol 25(1):31–36. https://doi.org/10.1016/j.ppedcard.2007.11.006
Dellefave L, McNally EM (2010) The genetics of dilated cardiomyopathy. Curr Opin Cardiol 25(3):198–204. https://doi.org/10.1097/HCO.0b013e328337ba52
Akinrinade O, Ollila L, Vattulainen S, Tallila J, Gentile M, Salmenperä P, Koillinen H, Kaartinen M, Nieminen MS, Myllykangas S, Alastalo TP, Koskenvuo JW, Heliö T (2015) Genetics and genotype-phenotype correlations in Finnish patients with dilated cardiomyopathy. Eur Heart J 36(34):2327–2337. https://doi.org/10.1093/eurheartj/ehv253
Merlo M, Pivetta A, Pinamonti B, Stolfo D, Zecchin M, Barbati G, Di Lenarda A, Sinagra G (2014) Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years. Eur J Heart Fail 16(3):317–324. https://doi.org/10.1002/ejhf.16
Jefferies JL, Towbin JA (2010) Dilated cardiomyopathy. Lancet (London, England) 375(9716):752–762. https://doi.org/10.1016/s0140-6736(09)62023-7
Long PA, Larsen BT, Evans JM, Olson TM (2015) Exome sequencing identifies pathogenic and modifier mutations in a child with sporadic dilated cardiomyopathy. J Am Heart Assoc 4(12):12. https://doi.org/10.1161/jaha.115.002443
Long PA, Zimmermann MT, Kim M, Evans JM, Xu X, Olson TM (2016) De novo RRAGC mutation activates mTORC1 signaling in syndromic fetal dilated cardiomyopathy. Hum Genet 135(8):909–917. https://doi.org/10.1007/s00439-016-1685-3
Simpson S, Edwards J, Ferguson-Mignan TF, Cobb M, Mongan NP, Rutland CS (2015) Genetics of human and canine dilated cardiomyopathy. Int J Genomics 2015:204823. https://doi.org/10.1155/2015/204823
Pérez-Serra A, Toro R, Sarquella-Brugada G, de Gonzalo-Calvo D, Cesar S, Carro E, Llorente-Cortes V, Iglesias A, Brugada J, Brugada R, Campuzano O (2016) Genetic basis of dilated cardiomyopathy. Int J Cardiol 224:461–472. https://doi.org/10.1016/j.ijcard.2016.09.068
Watkins H, Ashrafian H, Redwood C (2011) Inherited cardiomyopathies. N Engl J Med 364(17):1643–1656. https://doi.org/10.1056/NEJMra0902923
Jensen MK, Havndrup O, Christiansen M, Andersen PS, Diness B, Axelsson A, Skovby F, Køber L, Bundgaard H (2013) Penetrance of hypertrophic cardiomyopathy in children and adolescents: a 12-year follow-up study of clinical screening and predictive genetic testing. Circulation 127(1):48–54. https://doi.org/10.1161/circulationaha.111.090514
Precone V, Del Monaco V, Esposito MV, De Palma FD, Ruocco A, Salvatore F, D’Argenio V (2015) Cracking the code of human diseases using next-generation sequencing: applications. Chall Perspect 2015:161648. https://doi.org/10.1155/2015/161648
Herman DS, Lam L, Taylor MR, Wang L, Teekakirikul P, Christodoulou D, Conner L, DePalma SR, McDonough B, Sparks E, Teodorescu DL, Cirino AL, Banner NR, Pennell DJ, Graw S, Merlo M, Di Lenarda A, Sinagra G, Bos JM, Ackerman MJ, Mitchell RN, Murry CE, Lakdawala NK, Ho CY, Barton PJ, Cook SA, Mestroni L, Seidman JG, Seidman CE (2012) Truncations of titin causing dilated cardiomyopathy. N Engl J Med 366(7):619–628. https://doi.org/10.1056/NEJMoa1110186
Pettersen MD, Du W, Skeens ME, Humes RA (2008) Regression equations for calculation of z scores of cardiac structures in a large cohort of healthy infants, children, and adolescents: an echocardiographic study. J Am Soc Echocardiogr 21(8):922–934. https://doi.org/10.1016/j.echo.2008.02.006
Daubeney PE, Nugent AW, Chondros P, Carlin JB, Colan SD, Cheung M, Davis AM, Chow CW, Weintraub RG (2006) Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study. Circulation 114(24):2671–2678. https://doi.org/10.1161/circulationaha.106.635128
McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, DePristo MA (2010) The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20(9):1297–1303. https://doi.org/10.1101/gr.107524.110
DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, Philippakis AA, del Angel G, Rivas MA, Hanna M, McKenna A, Fennell TJ, Kernytsky AM, Sivachenko AY, Cibulskis K, Gabriel SB, Altshuler D, Daly MJ (2011) A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43(5):491–498. https://doi.org/10.1038/ng.806
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405–424. https://doi.org/10.1038/gim.2015.30
Stehlik J, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dobbels F, Kirk R, Rahmel AO, Hertz MI (2011) The registry of the international society for heart and lung transplantation: twenty-eighth adult heart transplant report-2011. J Heart Lung Transplant 30(10):1078–1094. https://doi.org/10.1016/j.healun.2011.08.003
McNally EM, Golbus JR, Puckelwartz MJ (2013) Genetic mutations and mechanisms in dilated cardiomyopathy. J Clin Investig 123(1):19–26. https://doi.org/10.1172/JCI62862
Martinez-Selles M, Doughty RN, Poppe K, Whalley GA, Earle N, Tribouilloy C, McMurray JJ, Swedberg K, Kober L, Berry C, Squire I (2012) Meta-Analysis Global Group In Chronic Heart, Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysis. Eur J Heart Fail 14(5):473–479. https://doi.org/10.1172/jci62862
Halliday BP, Gulati A, Ali A, Newsome S, Lota A, Tayal U, Vassiliou VS, Arzanauskaite M, Izgi C, Krishnathasan K, Singhal A, Chiew K, Gregson J, Frenneaux MP, Cook SA, Pennell DJ, Collins P, Cleland JGF, Prasad SK (2018) Sex- and age-based differences in the natural history and outcome of dilated cardiomyopathy. Eur J Heart Fail 20(10):1392–1400. https://doi.org/10.1002/ejhf.1216
Zhao Y, Feng Y, Zhang YM, Ding XX, Song YZ, Zhang AM, Liu L, Zhang H, Ding JH, Xia XS (2015) Targeted next-generation sequencing of candidate genes reveals novel mutations in patients with dilated cardiomyopathy. Int J Mol Med 36(6):1479–1486. https://doi.org/10.3892/ijmm.2015.2361
Pinto YM, Elliott PM, Arbustini E, Adler Y, Anastasakis A, Böhm M, Duboc D, Gimeno J, de Groote P, Imazio M, Heymans S, Klingel K, Komajda M, Limongelli G, Linhart A, Mogensen J, Moon J, Pieper PG, Seferovic PM, Schueler S, Zamorano JL, Caforio AL, Charron P (2016) Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J 37(23):1850–1858. https://doi.org/10.1093/eurheartj/ehv727
Ware SM, Wilkinson JD, Tariq M, Schubert JA, Sridhar A, Colan SD, Shi L, Canter CE, Hsu DT, Webber SA, Dodd DA, Everitt MD, Kantor PF, Addonizio LJ, Jefferies JL, Rossano JW, Pahl E, Rusconi P, Chung WK, Lee T, Towbin JA, Lal AK, Bhatnagar S, Aronow B, Dexheimer PJ, Martin LJ, Miller EM, Sleeper LA, Razoky H, Czachor J, Lipshultz SE (2021) Pediatric Cardiomyopathy Registry study, genetic causes of cardiomyopathy in children: first results from the pediatric cardiomyopathy genes study. J Am Heart Assoc 10(9):7731. https://doi.org/10.1161/JAHA.120.017731
Haggerty CM, Damrauer SM, Levin MG, Birtwell D, Carey DJ, Golden AM, Hartzel DN, Hu Y, Judy R, Kelly MA, Kember RL, Lester Kirchner H, Leader JB, Liang L, McDermott-Roe C, Babu A, Morley M, Nealy Z, Person TN, Pulenthiran A, Small A, Smelser DT, Stahl RC, Sturm AC, Williams H, Baras A, Margulies KB, Cappola TP, Dewey FE, Verma A, Zhang X, Correa A, Hall ME, Wilson JG, Ritchie MD, Rader DJ, Murray MF, Fornwalt BK, Arany Z (2019) Genomics-first evaluation of heart disease associated with titin-truncating variants. Circulation 140(1):42–54. https://doi.org/10.1161/CIRCULATIONAHA.119.039573
Fatkin D, Huttner IG (2017) Titin-truncating mutations in dilated cardiomyopathy: the long and short of it. Curr Opin Cardiol 32(3):232–238. https://doi.org/10.1097/hco.0000000000000382
Ellepola CD, Knight LM, Fischbach P, Deshpande SR (2018) Genetic testing in pediatric cardiomyopathy. Pediatr Cardiol 39(3):491–500. https://doi.org/10.1007/s00246-017-1779-2
Vasilescu C, Ojala TH, Brilhante V, Ojanen S, Hinterding HM, Palin E, Alastalo TP, Koskenvuo J, Hiippala A, Jokinen E, Jahnukainen T, Lohi J, Pihkala J, Tyni TA, Carroll CJ, Suomalainen A (2018) Genetic basis of severe childhood-onset cardiomyopathies. J Am Coll Cardiol 72(19):2324–2338. https://doi.org/10.1016/j.jacc.2018.08.2171
Dai G, Pu Z, Cheng X, Yin J, Chen J, Xu T, Zhang H, Li Z, Chen X, Chen J, Qin Y, Yang S (2019) Whole-exome sequencing reveals novel genetic variation for dilated cardiomyopathy in pediatric Chinese patients. Pediatr Cardiol 40(5):950–957. https://doi.org/10.1007/s00246-019-02096-1
Zaklyazminskaya E, Mikhailov V, Bukaeva A, Kotlukova N, Povolotskaya I, Kaimonov V, Dombrovskaya A, Dzemeshkevich S (2019) Low mutation rate in the TTN gene in paediatric patients with dilated cardiomyopathy—a pilot study. Sci Rep 9(1):16409. https://doi.org/10.1038/s41598-019-52911-1
Jansweijer JA, Nieuwhof K, Russo F, Hoorntje ET, Jongbloed JD, Lekanne Deprez RH, Postma AV, Bronk M, van Rijsingen IA, de Haij S, Biagini E, van Haelst PL, van Wijngaarden J, van den Berg MP, Wilde AA, Mannens MM, de Boer RA, van Spaendonck-Zwarts KY, van Tintelen JP, Pinto YM (2017) Truncating titin mutations are associated with a mild and treatable form of dilated cardiomyopathy. Eur J Heart Fail 19(4):512–521. https://doi.org/10.1002/ejhf.673
Felkin LE, Walsh R, Ware JS, Yacoub MH, Birks EJ, Barton PJ, Cook SA (2016) Recovery of cardiac function in cardiomyopathy caused by titin truncation. JAMA Cardiol 1(2):234–235. https://doi.org/10.1001/jamacardio.2016.0208
Anderson JL, Christensen GB, Escobar H, Horne BD, Knight S, Jacobs V, Afshar K, Hebl VB, Muhlestein JB, Knowlton KU, Carlquist JF, Nadauld LD (2020) Discovery of TITIN gene truncating variant mutations and 5-year outcomes in patients with nonischemic dilated cardiomyopathy. Am J Cardiol 137:97–102. https://doi.org/10.1016/j.amjcard.2020.09.026
Tobita T, Nomura S, Fujita T, Morita H, Asano Y, Onoue K, Ito M, Imai Y, Suzuki A, Ko T, Satoh M, Fujita K, Naito AT, Furutani Y, Toko H, Harada M, Amiya E, Hatano M, Takimoto E, Shiga T, Nakanishi T, Sakata Y, Ono M, Saito Y, Takashima S, Hagiwara N, Aburatani H, Komuro I (2018) Genetic basis of cardiomyopathy and the genotypes involved in prognosis and left ventricular reverse remodeling. Sci Rep 8(1):1998. https://doi.org/10.1038/s41598-018-20114-9
Verdonschot JAJ, Hazebroek MR, Derks KWJ, Barandiaran Aizpurua A, Merken JJ, Wang P, Bierau J, van den Wijngaard A, Schalla SM, Abdul Hamid MA, van Bilsen M, van Empel VPM, Knackstedt C, Brunner-La Rocca HP, Brunner HG, Krapels IPC, Heymans SRB (2018) Titin cardiomyopathy leads to altered mitochondrial energetics, increased fibrosis and long-term life-threatening arrhythmias. Eur Heart J 39(10):864–873. https://doi.org/10.1093/eurheartj/ehx808
Kayvanpour E, Sedaghat-Hamedani F, Amr A, Lai A, Haas J, Holzer DB, Frese KS, Keller A, Jensen K, Katus HA, Meder B (2017) Genotype-phenotype associations in dilated cardiomyopathy: meta-analysis on more than 8000 individuals. Clin Res Cardiol 106(2):127–139. https://doi.org/10.1007/s00392-016-1033-6
Watanabe T, Kimura A, Kuroyanagi H (2018) Alternative splicing regulator RBM20 and cardiomyopathy. Front Mol Biosci 5:105. https://doi.org/10.3389/fmolb.2018.00105
Miszalski-Jamka K, Jefferies JL, Mazur W, Głowacki J, Hu J, Lazar M, Gibbs RA, Liczko J, Kłyś J, Venner E, Muzny DM, Rycaj J, Białkowski J, Kluczewska E, Kalarus Z, Jhangiani S, Al-Khalidi H, Kukulski T, Lupski JR, Craigen WJ, Bainbridge MN (2017) Novel genetic triggers and genotype-phenotype correlations in patients with left ventricular noncompaction, circulation. Cardiovasc Genet 10(4):20. https://doi.org/10.1161/circgenetics.117.001763
Parikh VN, Caleshu C, Reuter C, Lazzeroni LC, Ingles J, Garcia J, McCaleb K, Adesiyun T, Sedaghat-Hamedani F, Kumar S, Graw S, Gigli M, Stolfo D, Dal Ferro M, Ing AY, Nussbaum R, Funke B, Wheeler MT, Hershberger RE, Cook S, Steinmetz LM, Lakdawala NK, Taylor MRG, Mestroni L, Merlo M, Sinagra G, Semsarian C, Meder B, Judge DP, Ashley E (2019) Regional variation in RBM20 causes a highly penetrant arrhythmogenic cardiomyopathy. Circ Heart Fail 12(3):e005371. https://doi.org/10.1161/CIRCHEARTFAILURE.118.005371
Hoedemaekers YM, Cohen-Overbeek TE, Frohn-Mulder IM, Dooijes D, Majoor-Krakauer DF (2013) Prenatal ultrasound diagnosis of MYH7 non-compaction cardiomyopathy. Ultrasound Obstet Gynecol 41(3):336–339
Genomics of complex disorders I (2008) Genome Med 2(3–4) 303–330. https://doi.org/10.1007/s11568-009-9104-7
Cuenca S, Ruiz-Cano MJ, Gimeno-Blanes JR, Jurado A, Salas C, Gomez-Diaz I, Padron-Barthe L, Grillo JJ, Vilches C, Segovia J, Pascual-Figal D, Lara-Pezzi E, Monserrat L, Alonso-Pulpon L, Garcia-Pavia P (2016) Genetic basis of familial dilated cardiomyopathy patients undergoing heart transplantation. Transplantation 35(5):625–635. https://doi.org/10.1016/j.healun.2015.12.014
Lakdawala NK, Funke BH, Baxter S, Cirino AL, Roberts AE, Judge DP, Johnson N, Mendelsohn NJ, Morel C, Care M, Chung WK, Jones C, Psychogios A, Duffy E, Rehm HL, White E, Seidman JG, Seidman CE, Ho CY (2012) Genetic testing for dilated cardiomyopathy in clinical practice. J Cardiac Fail 18(4):296–303. https://doi.org/10.1016/j.cardfail.2012.01.013
Walsh R, Thomson KL, Ware JS, Funke BH, Woodley J, McGuire KJ, Mazzarotto F, Blair E, Seller A, Taylor JC, Minikel EV, Exome Aggregation C, MacArthur DG, Farrall M, Cook SA, Watkins H (2017) Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genetics Med 19(2):192–203. https://doi.org/10.1038/gim.2016.90
Meng L, Pammi M, Saronwala A, Magoulas P, Ghazi AR, Vetrini F, Zhang J, He W, Dharmadhikari AV, Qu C, Ward P, Braxton A, Narayanan S, Ge X, Tokita MJ, Santiago-Sim T, Dai H, Chiang T, Smith H, Azamian MS, Robak L, Bostwick BL, Schaaf CP, Potocki L, Scaglia F, Bacino CA, Hanchard NA, Wangler MF, Scott D, Brown C, Hu J, Belmont JW, Burrage LC, Graham BH, Sutton VR, Craigen WJ, Plon SE, Lupski JR, Beaudet AL, Gibbs RA, Muzny DM, Miller MJ, Wang X, Leduc MS, Xiao R, Liu P, Shaw C, Walkiewicz M, Bi W, Xia F, Lee B, Eng CM, Yang Y, Lalani SR (2017) Use of exome sequencing for infants in intensive care units: ascertainment of severe single-gene disorders and effect on medical management. JAMA Pediatr 171(12):e173438. https://doi.org/10.1001/jamapediatrics.2017.3438
Funding
This study was funded by the Natural Science Foundation of China (Grant Number: 81873498), the Natural Science Foundation of Shandong Province (Grant Number: ZR2019MH015), the Jinan Science and Technology Development Plan (Grant Number 201805020), and Special Expert of Taishan Scholars (Grant Number: TS201511099).
Author information
Authors and Affiliations
Contributions
All authors contributed to study conception and design. YW and BH collected patient data and prepared the manuscript. YF, XY, JL, and JW contributed to the clinical evaluation of patients and revision of the manuscript. YY, HY, LZ, and JZ analyzed and interpreted the genetic data and surveyed the literature relevant to the mutations. All authors reviewed the results and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Consent to Participate
N/A.
Consent for Publication
All authors and study participants declare their unconditional consent toward publication of this manuscript and its associated data in a peer-reviewed journal.
Ethical Approval
Our study received ethics approval (NSFC: NO.2018-115) from the ethics committee of Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University.
Informed Consent
Informed consent was obtained from the parents or carers of all participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Wang, Y., Han, B., Fan, Y. et al. Next-Generation Sequencing Reveals Novel Genetic Variants for Dilated Cardiomyopathy in Pediatric Chinese Patients. Pediatr Cardiol 43, 110–120 (2022). https://doi.org/10.1007/s00246-021-02698-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-021-02698-8